Frey, L.; Klümper, N.; Schmidt, D.; Kristiansen, G.; Toma, M.; Ritter, M.; Alajati, A.; Ellinger, J.
CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma. Cancers 2021, 13, 2177.
https://doi.org/10.3390/cancers13092177
AMA Style
Frey L, Klümper N, Schmidt D, Kristiansen G, Toma M, Ritter M, Alajati A, Ellinger J.
CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma. Cancers. 2021; 13(9):2177.
https://doi.org/10.3390/cancers13092177
Chicago/Turabian Style
Frey, Lisa, Niklas Klümper, Doris Schmidt, Glen Kristiansen, Marieta Toma, Manuel Ritter, Abdullah Alajati, and Jörg Ellinger.
2021. "CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma" Cancers 13, no. 9: 2177.
https://doi.org/10.3390/cancers13092177
APA Style
Frey, L., Klümper, N., Schmidt, D., Kristiansen, G., Toma, M., Ritter, M., Alajati, A., & Ellinger, J.
(2021). CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma. Cancers, 13(9), 2177.
https://doi.org/10.3390/cancers13092177